{"id":"https://openalex.org/W68164476","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.730.28","title":"Upregulation of cardiac interstitial chymase after canine myocardial ischemia and reperfusion","display_name":"Upregulation of cardiac interstitial chymase after canine myocardial ischemia and reperfusion","publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W68164476","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.730.28","mag":"68164476"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.22.1_supplement.730.28","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.730.28","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.22.1_supplement.730.28","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110138708","display_name":"Chih\u2010Chang Wei","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chih\u2010Chang Wei","raw_affiliation_strings":["Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043274700","display_name":"Naoki Hase","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Hase","raw_affiliation_strings":["Pharmacology &amp; Safety Research TEIJIN Pharma Limited Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology &amp; Safety Research TEIJIN Pharma Limited Tokyo Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040621036","display_name":"Eddie W. Bradley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eddie W. Bradley","raw_affiliation_strings":["Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ke Shi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ke Shi","raw_affiliation_strings":["Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044140971","display_name":"Tsunefuni Kobayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsunefuni Kobayashi","raw_affiliation_strings":["Pharmacology &amp; Safety Research TEIJIN Pharma Limited Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology &amp; Safety Research TEIJIN Pharma Limited Tokyo Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012443758","display_name":"Cheryl R. Killingsworth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl R. Killingsworth","raw_affiliation_strings":["Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014084766","display_name":"Gregory P. Walcott","orcid":"https://orcid.org/0000-0002-9807-7422","observed_orcids":["https://orcid.org/0000-0002-9807-7422"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory P. Walcott","raw_affiliation_strings":["Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016527938","display_name":"Ahsan Husain","orcid":"https://orcid.org/0000-0003-3426-3469","observed_orcids":["https://orcid.org/0000-0003-3426-3469"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahsan Husain","raw_affiliation_strings":["Physiology &amp; Biophysics University of Alabama at Birmingham Birmingham AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiology &amp; Biophysics University of Alabama at Birmingham Birmingham AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053149684","display_name":"Louis J. Dell\u2019Italia","orcid":"https://orcid.org/0000-0001-6654-0665","observed_orcids":["https://orcid.org/0000-0001-6654-0665"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis J Dell'Italia","raw_affiliation_strings":["Medicine","Physiology &amp; Biophysics University of Alabama at Birmingham Birmingham AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine","institution_ids":[]},{"raw_affiliation_string":"Physiology &amp; Biophysics University of Alabama at Birmingham Birmingham AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.2371,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.61223109,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"22","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.7310000061988831,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.7310000061988831,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.11710000038146973,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.039900001138448715,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chymase","display_name":"chymase","score":0.9010000228881836},{"id":"https://openalex.org/keywords/myocardial-ischemia","display_name":"myocardial ischemia","score":0.7760000228881836},{"id":"https://openalex.org/keywords/ischemia-reperfusion-injury","display_name":"ischemia-reperfusion injury","score":0.902999997138977},{"id":"https://openalex.org/keywords/mast-cells","display_name":"mast cells","score":0.8650000095367432},{"id":"https://openalex.org/keywords/chymase-inhibitors","display_name":"chymase inhibitors","score":0.6980000138282776},{"id":"https://openalex.org/keywords/matrix-metalloproteinase-activation","display_name":"matrix metalloproteinase activation","score":0.7450000047683716},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.7699999809265137},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.8019999861717224},{"id":"https://openalex.org/keywords/canine-model","display_name":"canine model","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C2780614898","wikidata":"https://www.wikidata.org/wiki/Q5118578","display_name":"Chymase","level":3,"score":0.9824419021606445},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6207693219184875},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5380864143371582},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5303680896759033},{"id":"https://openalex.org/C2779726688","wikidata":"https://www.wikidata.org/wiki/Q191989","display_name":"Mast cell","level":2,"score":0.4915483891963959},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.488619863986969},{"id":"https://openalex.org/C2779822359","wikidata":"https://www.wikidata.org/wiki/Q2914458","display_name":"Interstitial fluid","level":2,"score":0.42587709426879883},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.42552316188812256},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4059741497039795},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3839649558067322},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3249048590660095},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13437408208847046},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10069867968559265}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.22.1_supplement.730.28","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.730.28","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.22.1_supplement.730.28","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.5299999713897705,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2015077604","https://openalex.org/W2023531166","https://openalex.org/W2034700253","https://openalex.org/W2102027213","https://openalex.org/W1516244477","https://openalex.org/W2491228224","https://openalex.org/W1988282390","https://openalex.org/W1533602708","https://openalex.org/W2031977380","https://openalex.org/W2272528191"],"abstract_inverted_index":{"The":[0,117,185],"serine":[1],"protease":[2],"chymase":[3,52,94,119,156,168,192,220],"is":[4,12,69],"stored":[5],"in":[6,61,82,86,121,170,193,205,223,230,239],"mast":[7,15,67,202],"cell":[8,16,203],"secretory":[9],"granules":[10],"and":[11,30,49,80,138,154,176,208,237],"released":[13,70],"upon":[14],"activation":[17],"into":[18,71],"the":[19,55,72,105,122,171,214,224],"cardiac":[20,47,73,98,218],"interstitium":[21,74],"where":[22],"it":[23,139],"activates":[24],"matrix":[25],"metalloproteinases,":[26],"causes":[27],"cardiomyocyte":[28],"apoptosis,":[29],"generates":[31],"angiotensin":[32],"(Ang)":[33],"II.":[34],"Miyazaki":[35],"et.":[36],"al":[37],".":[38],"(Life":[39],"Sci.":[40],"71:437,":[41],"2002)":[42],"reported":[43],"beneficial":[44],"effects":[45],"on":[46],"function":[48],"survival":[50],"of":[51,58,104],"inhibition":[53],"during":[54],"acute":[56,76,228],"phase":[57],"myocardial":[59,77],"infarction":[60],"hamsters.":[62],"Here":[63],"we":[64,96],"determined":[65],"if":[66],"cell\u2010chymase":[68],"after":[75,115,130,174,227],"ischemia":[78],"(MI)":[79],"reperfusion":[81,137,175],"dogs.":[83],"To":[84],"measure":[85],"vivo":[87,194],"left":[88],"ventricle":[89],"(LV)":[90],"interstitial":[91,219],"fluid":[92],"(ISF)":[93],"activity,":[95],"combined":[97],"microdialysis":[99],"with":[100],"direct":[101],"ISF":[102,118,167,191],"infusion":[103],"chymase\u2010specific":[106],"substrate":[107],"[Pro":[108],"11":[109],",":[110],"DAla":[111],"12":[112],"]Ang":[113],"I":[114],"MI.":[116],"activity":[120,169],"ischemic":[123],"region":[124,173],"was":[125,140,161,179],"3.5\u2010fold":[126],"(n=6,":[127,164],"p<0.001)":[128,165],"increased":[129,166],"60":[131],"min":[132,136],"MI":[133,207,229],"followed":[134],"100":[135],"significantly":[141],"suppressed":[142],"by":[143,182,198,233],"TEI\u2010F00806":[144],"(100":[145],"mg/kg/BID,":[146],"pretreated":[147],"5":[148],"days),":[149],"a":[150],"novel,":[151],"orally":[152],"active":[153],"specific":[155],"inhibitor":[157],"(CI).":[158],"Importantly,":[159],"there":[160],"also":[162],"5\u2010fold":[163],"non\u2010ischemic":[172],"this":[177],"increase":[178],"completely":[180],"blocked":[181],"CI":[183],"treatment.":[184],"current":[186],"investigation":[187],"indicates":[188],"that":[189,200,217],"LV":[190],"can":[195],"be":[196],"regulated":[197],"factors":[199],"affect":[201],"activation,":[204],"particular,":[206],"reperfusion.":[209],"These":[210],"findings":[211],"demonstrated":[212],"for":[213],"first":[215],"time":[216],"participates":[221],"directly":[222],"pathophysiologic":[225],"state":[226],"dog.":[231],"Supported":[232],"TEIJIN":[234],"Pharma":[235],"Limited":[236],"SCCOR":[238],"Cardiac":[240],"Dysfunction":[241],"P50HL077100":[242],"(LJD).":[243]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}